MedPlus Health Services Limited (formerly known as MedPlus Health Services

 

Annexure- VIL
Notes to Restated Consolidated Financial Information
(All amounts are it Rs in millions except as others stated)

43, Related party Disclosure (continued)
(c) Amounts due (toVfrom related partis: (these transactions got eliminated in Restated Consolidated Financial Information)

 

 

September 302021 September 30,2020 ‘March 31,2031 March 31,2020 March 31,2019
() In the books of the Company:
1. Optival Health Solutions Private Limited 12431 578 11476, 726 2050
2. Agilemed Investments Private Limited 0.00 5.80 oot 0.80 o77
3. MHS Pharmaceuticals Private Limited (1) (oo) (083) oot 042
4. Wynelark Pharmaceuticals Private Limited 0s . 013. 0.02 :
5. Kalyani Meditimes Private Limited 16.93 45. 450 . :
i) In the books of the Optival Health Solutions Private Limited:
Wynclark Pharmaceuticals Private Limited* 750) 1.03, (501) (720) (0.08)
MHS Pharmaceuticals Private Limited (6430) (102.40) (48.79) (7850) 79.17)
‘Sai Sridhar Pharma Private Limited
‘Trade payables (956.93) (20700) (135.3) (293.40) sr)
‘Claims receivable 2484 2593 1057 7 820
Venkata Krishna Enterprises Private Limited "
‘Trade payables (269.08) 1724) (22139) (405.46) (138.40)
‘Claims receivable 2153 22.26 0x2 232 577
Deccan Medicals Private Limited
Trade payables (00.30) (ss) (65.76) (e407 7450)
Claims receivable 1520 1175 509 1st 491
Shri Banashankari Pharma Private Limited
‘Trade payables (0.05) 339) (0.66) (140) (106)
Claims receivable 0.09 099 0.09 075 234
Sidson Pharma Distributors Private Limited
Trade payables (144.05) (126.13) (79.23) (156.65) (60.00)
Claims receivable 859 820 227 161 un
Nova Sud Pharmacuticals Private Limited
Trade payables (136) 0.00 (1.35) : :
Kalyani Meditimes Private Limited Z 0.00 Z . :

* Accrued discount of Rs. Nil (September 30,2020 : Rs 1.36, March 31, 2021 : Rs Nil, March 31, 2020 Rs Nil, March 31, 2019 Rs Nil) are not included.
% Acerued discount of Rs 4.25 millions (September 30, 2020: Rs 618 millions, March 31, 2021: Rs 278 millions, March 31, 2020 : Rs 8.78 millions, 31 March 2019: Rs.7.60 millions) are not included.

‘ Acerued discount of Rs. Nil (September 30, 2020: Rs. Nil, March 31, 2021: Rs Nil, March 31, 2020 Rs 0.85 millions, 31 March 2019: Rs.1.47 millions) are not included,

(Gi) In the books of the Wynclark Pharmaceuticals Private Limited:
‘Sai Sridhar Pharma Private Limited 01s - 005 :

(iv) In the books of the Sidson Pharma Distributors Private Limited:
‘Sai Sridhar Pharma Private Limited - oa - 01s

002

‘The Holding Company subscribed to 9,999 shares of 10 each of ClearanceKart Private Limited, which was incorporated on 09 March 2021 under the Companies Act2013. The transfer of shares and consideration

happened during the six months period ended September 30, 2021

44, Fair Values

 

Refer note 22 (for accounting policy on financial instruments
Set out below, isa comparison by class of the carrying amounts and fair value ofthe Group's financial instruments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ganying value
September 30,2021 September 30,2020 ‘March 31, 2021 March 31,2020 March 34,2019
Financial assets
Financial assets at amortised cost:
a) Investments 033 ox 03 254 -
b) Trade receivables 0s 40.64 5367 400 8754
3) Loans Z - - - :
8) Cashand cash equivalents 256.78, 418.45, 1068.16 1139.16 25083,
©) Bank balances other than above 703.70 303.90 1779 267.76 248.24
1) Other financial assets 1,089.66 968.71 910.23, 582.10 a7
‘Total Financial assets 2,082.55 TR 215018 2055.56 1065.95
Financial liabilities
Financial liabilities at amortised cost:
a) Borrowings 567.48 863.82 135235 1,050.51 1044.02
b) Trade payables 20508 1813.07 1480.98 23H 1581.22
©) Other financial liabilities 561.76 532.22 384.95, 451, 292.75
‘Total Financial Liabilities 336828 3209.7 3218.26 TSS 2517.99
Tair value
September30,2021 September 30,2020 ‘March 31, 2021 March 31, 2020 March 34,2019,
Financial assets
Financial assets at amortised cost:
a) Investments 033 033 033 254 2
b) Trade receivables 7.08 40.64 53.67 64.00 8754
©) Loans 2 a E z f
4) Cashand cash equivalents 256.78, 418.45, 1,068.16 1139.16 25083,
©) Bank balances other than above 703.70 303.90 11779 267.76 248.24
1) Other financial assets 1,089.66 968.71 910.23, 582.10 470.4
‘Total Financial assets 2,082.55 TRL 25018 205556 1065.95
Financial liabilities
Financial liabilities at amortised cost:
8) Borrowings 567.48, 86382 135235 1105051 144.02
>) Trade payables 20508 1s13.07 1480.98 2341.51 4581.22
©) Other financial liabilities 561.76 532.22 384.93, 45151 292.75
‘Total Financial Liabilities 336828 S200. 321826 TSBs 2917 99

 

‘The fair value of the financial assets and liabilities is included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale

269
